FINAL IVUS RESULTS FROM THE DESSOLVE–I FIRST–IN–HUMAN TRIAL: LONG–TERM ARTERIAL RESPONSE TO A NOVEL SIROLIMUS–ELUTING STENT WITH FULLY ABSORBABLE POLYMER AND CRYSTALLINE DRUG

The MiStent is a new drug–eluting stent characterized by the use of crystalline sirolimus and a fully absorbable PLGA polymer on a thin–strut (64 µm) cobalt–chromium stent. Prior preclinical studies showed the stent coating being eliminated in 45–60 days with full absorption of the polymer